These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6186896)
41. Local immunity to klebsiella pneumoniae in the lungs of mice. Cooper JM; Finlay-Jones JJ; Hill NL; Rowley D J Infect Dis; 1983 Feb; 147(2):312-7. PubMed ID: 6338131 [TBL] [Abstract][Full Text] [Related]
42. Development of immunization trials against Klebsiella pneumoniae. Ahmad TA; El-Sayed LH; Haroun M; Hussein AA; El Ashry el SH Vaccine; 2012 Mar; 30(14):2411-20. PubMed ID: 22100884 [TBL] [Abstract][Full Text] [Related]
43. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027 [TBL] [Abstract][Full Text] [Related]
45. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae. Young LS; Stevens P J Infect Dis; 1977 Aug; 136 Suppl():S174-80. PubMed ID: 19538 [TBL] [Abstract][Full Text] [Related]
46. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge. Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182 [TBL] [Abstract][Full Text] [Related]
47. Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity. Lee WH; Choi HI; Hong SW; Kim KS; Gho YS; Jeon SG Exp Mol Med; 2015 Sep; 47(9):e183. PubMed ID: 26358222 [TBL] [Abstract][Full Text] [Related]
48. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide. Cryz SJ; Fürer E; Germanier R Infect Immun; 1984 Jul; 45(1):139-42. PubMed ID: 6376353 [TBL] [Abstract][Full Text] [Related]
49. Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate. Lee CJ; Lock RA; Andrew PW; Mitchell TJ; Hansman D; Paton JC Vaccine; 1994 Aug; 12(10):875-8. PubMed ID: 7975828 [TBL] [Abstract][Full Text] [Related]
50. Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides. Lee CJ; Koizumi K J Immunol; 1981 Oct; 127(4):1619-23. PubMed ID: 6792279 [TBL] [Abstract][Full Text] [Related]
51. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae. Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744 [TBL] [Abstract][Full Text] [Related]
52. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Brown JS; Ogunniyi AD; Woodrow MC; Holden DW; Paton JC Infect Immun; 2001 Nov; 69(11):6702-6. PubMed ID: 11598041 [TBL] [Abstract][Full Text] [Related]
53. Protective immunity elicited by rBCG vaccines. Stover CK; Bansal GP; Langerman S; Hanson MS Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471 [TBL] [Abstract][Full Text] [Related]
54. Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier. Deauvieau F; Dussurgey S; Rossignol D; de Montfort A; Burdin N; Guy B Vaccine; 2009 Dec; 28(2):576-82. PubMed ID: 19878751 [TBL] [Abstract][Full Text] [Related]
57. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice. Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026 [TBL] [Abstract][Full Text] [Related]
58. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1. McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102 [TBL] [Abstract][Full Text] [Related]
59. [Capsular polysaccharide of Klebsiella pneumoniae. II. Immunogenic properties]. Alcántar-Curiel MD; Martínez-Ramos A; García-Latorre E Rev Latinoam Microbiol; 1993; 35(1):109-15. PubMed ID: 8140330 [TBL] [Abstract][Full Text] [Related]
60. Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium. Hoops P; Prather NE; Berry J; Ravel JM Infect Immun; 1976 Apr; 13(4):1184-92. PubMed ID: 776831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]